Results 51 to 60 of about 8,919 (185)
Pretibial epidermolysis bullosa
A 47-year-old Vietnamese woman presented with dystrophic fingernails and toenails that had been present since infancy. She also had developed, in the third decade, pretibial pruritus with vesicle formation and progressive localized papules and scars. Multiple family members were similarly affected.
Rizzo, Carina +6 more
openaire +4 more sources
ABSTRACT The coexistence of LOCS and a broader EB phenotype within a single consanguineous family represents a unique instance of intra‐familial phenotypic heterogeneity in LAMA3‐related junctional epidermolysis bullosa. This highlights the importance of recognizing systemic manifestations, including urological and neurological complications, and ...
Zainab Rasheed +5 more
wiley +1 more source
Tutorial on Analyzing Patient‐Reported Outcome Measures in Clinical Development
ABSTRACT Patient‐reported outcomes (PROs) are now considered essential components of clinical development and regulatory assessment. Despite their widespread collection, PRO data remain under‐utilized, with analyses often limited to descriptive summaries or single time‐point comparisons that fail to capture the richness, longitudinal structure, and ...
Krina Mehta +4 more
wiley +1 more source
Epidermolysis bullosa acquisita
A 20 year old male started developing bubae following even minor trauma on the skin as well as the mucous membranes during the preceding 5 years. The bunae healed with atrophic scars. Involvement of the oral mucous membrane and the eyes, scpcially the right eye, was quite extensive and unusual.
Jayanta Kr, Das +2 more
openaire +2 more sources
Gene Therapy for Dystrophic Epidermolysis Bullosa
ABSTRACT Dystrophic epidermolysis bullosa (DEB) is a rare, debilitating genodermatosis caused by loss‐of‐function variants in COL7A1, resulting in type VII collagen (C7) deficiency and defective anchoring fibrils, which are essential for dermal–epidermal adhesion.
Cristina Has, Meropi Karakioulaki
wiley +1 more source
Application of biomedical cell products in the treatment of congenital epidermolysis bullosa [PDF]
Congenital epidermolysis bullosa is a phenotypically and genetically heterogeneous group of genodermatoses, which are characterized by decreasing of skin’s structural protein production up to complete absence or violation of the structure as a result of ...
Arfenya E. Karamova +3 more
doaj +1 more source
Nutritional aspects of children and adolescents with epidermolysis bullosa: literature review [PDF]
Epidermolysis Bullosa is a genetic disorder that affects mainly the skin, however, all others systems are influenced. The nutritional care of children and adolescents with Epidermolysis Bullosa is a key treatment strategy, since the energy needs are ...
Ana Paula Caio Zidorio +3 more
doaj +2 more sources
Cell Adhesion by Design: Engineering Tissue Culture Scaffolds With Adhesion Cues
ABSTRACT In scaffold‐based tissue engineering, the matrix should provide adequate adhesion cues for cell attachment, spreading, and function. Given the multitude of adhesion receptors and the diversity of scaffolds, there are many approaches to render scaffolds adhesive, even though they are not all equivalent.
Dalia Dranseike +3 more
wiley +1 more source
Circulating anti-type VII collagen autoantibodies are frequently detected in patients with recessive dystrophic epidermolysis bullosa (RDEB). However, evidence supporting their pathogenic role in inducing epidermolysis bullosa acquisita (EBA) has been ...
Liliana Guerra +6 more
doaj +1 more source
Management of Pain and Pruritus in Pediatric Recessive Dystrophic Epidermolysis Bullosa
ABSTRACT The current report presents a tailored and efficient pain management strategy for a 7‐year old boy with recessive dystrophic epidermolysis bullosa severe generalized. Successful management of pain associated with demanding wound care was achieved through a combination of oral pregabalin, topical gabapentin–lidocaine, and psychological ...
Maiju K. Marttinen +4 more
wiley +1 more source

